Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
The XIST lncRNA is a sex-specific reservoir of TLR7 ligands in SLE
Jonathan D. Crawford, Hong Wang, Daniela Trejo-Zambrano, Raffaello Cimbro, C. Conover Talbot Jr., Mekha A. Thomas, Ashley M. Curran, Alexander A. Girgis, John T. Schroeder, Andrea Fava, Daniel W. Goldman, Michelle Petri, Antony Rosen, Brendan Antiochos, Erika Darrah
Jonathan D. Crawford, Hong Wang, Daniela Trejo-Zambrano, Raffaello Cimbro, C. Conover Talbot Jr., Mekha A. Thomas, Ashley M. Curran, Alexander A. Girgis, John T. Schroeder, Andrea Fava, Daniel W. Goldman, Michelle Petri, Antony Rosen, Brendan Antiochos, Erika Darrah
View: Text | PDF
Research Article Immunology

The XIST lncRNA is a sex-specific reservoir of TLR7 ligands in SLE

  • Text
  • PDF
Abstract

Systemic lupus erythematosus (SLE) is a systemic autoimmune disease with a dramatic sex bias, affecting 9 times more women than men. Activation of Toll-like receptor 7 (TLR7) by self-RNA is a central pathogenic process leading to aberrant production of type I interferon (IFN) in SLE, but the specific RNA molecules that serve as TLR7 ligands have not been defined. By leveraging gene expression data and the known sequence specificity of TLR7, we identified the female-specific X-inactive specific transcript (XIST) long noncoding RNA as a uniquely rich source of TLR7 ligands in SLE. XIST RNA stimulated IFN-α production by plasmacytoid DCs in a TLR7-dependent manner, and deletion of XIST diminished the ability of whole cellular RNA to activate TLR7. XIST levels were elevated in blood leukocytes from women with SLE compared with controls, correlated positively with disease activity and the IFN signature, and were enriched in extracellular vesicles released from dying cells in vitro. Importantly, XIST was not IFN inducible, suggesting that XIST is a driver, rather than a consequence, of IFN in SLE. Overall, our work elucidated a role for XIST RNA as a female sex–specific danger signal underlying the sex bias in SLE.

Authors

Jonathan D. Crawford, Hong Wang, Daniela Trejo-Zambrano, Raffaello Cimbro, C. Conover Talbot Jr., Mekha A. Thomas, Ashley M. Curran, Alexander A. Girgis, John T. Schroeder, Andrea Fava, Daniel W. Goldman, Michelle Petri, Antony Rosen, Brendan Antiochos, Erika Darrah

×

Figure 3

XIST knockdown diminishes TLR7-activating potential of whole cellular RNA.

Options: View larger image (or click on image) Download as PowerPoint

XIST knockdown diminishes TLR7-activating potential of whole cellular R...
(A) A431 cells were targeted with CRISPR/Cas9 technology to generate XIST-depleted XIST-A and XIST-B cell populations. Representative RNAScope images showing XIST expression (green) and nuclei (blue) in WT, pCAS, XIST-A, and XIST-B cultures. Scale bar indicates 20 μm. (B) Percentage of XIST-positive cells was determined by masked quantification of 10 randomly chosen RNAScope image fields per cell population. (C) Bar graph showing XIST expression in terms of fragments per kilobase of exon per million mapped fragments (FPKM) in each cell population as measured by RNA sequencing. The dotted line at y = 7 shows the lower limit of detection in our RNA-sequencing experiment. (D) Colorimetric assay measuring SEAP secretion by HEK-hTLR7 cells transfected with fragmented cellular RNA from WT, pCAS, XIST-A, or XIST-B cells. Results shown are pooled from 3 independent experiments. (E) Bar graph showing XIST expression in WT, XIST-KO, and Jurkat cells as measured by qPCR. XIST expression calculated using the ΔΔCt method using GAPDH as an internal control and the WT cell line as the reference. (F) Colorimetric assay measuring SEAP secretion by HEK-hTLR7 cells transfected with fragmented cellular RNA from either WT or XIST-KO A431 cells. (B–F) All conditions compared with WT by multiple comparisons within 1-way ANOVA with multiple-comparison correction. ** indicates P < 0.01, *** indicates P < 0.001, and **** indicates P < 0.0001. (F) Conditions compared by unpaired t test. (B–F) Error bars represent 1 SD.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts